Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ginkgo leaf dropping pills
- Development stage
- Unknown
- Lead developer
- Wanbangde Pharmaceutical Group
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Ginkgo Leaf Dropping Pills (银杏叶滴丸) is a standardized Traditional Chinese Medicine (TCM) product developed and marketed by Wanbangde Pharmaceutical Group. Formulated as dropping pills for oral administration, the drug contains a concentrated extract of *Ginkgo biloba* leaves, standardized for active constituents such as flavonoids and terpene lactones (ginkgolides and bilobalide). It is primarily indicated for the prevention and treatment of cardiovascular and cerebrovascular diseases, including ischemic stroke, as well as retinal degenerative diseases. The pharmacological action of the pills involves the inhibition of platelet-activating factor (PAF) receptors, which reduces platelet aggregation and improves blood rheology, alongside potent antioxidant effects that protect vascular endothelial cells and neurons from oxidative stress-induced damage.
- Brand names
- Ginkgo Leaf Dropping Pills
- Other names
- 银杏叶滴丸Yinxingye Diwan
02
Targets
PTAFR (Platelet-activating factor receptor)
Beyond the preview
Go deeper on ginkgo leaf dropping pills.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ginkgo leaf dropping pills.